drug
BMS-986446
Phase 2updated 3mo agoby Bristol-Myers Squibb Co
Phase 2community read0 votes
indications
indications
Alzheimer's Disease
all catalysts(0)
nothing on the calendar yet
Trials studying BMS-986446
- phase1A Study to Assess Drug Levels, Tolerability and Absolute Biological Availability of Single-dose of BMS-986446 in Healthy Participants
- phase2Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease
- phase1A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986446 in Healthy Participants and Healthy Participants of Japanese Ethnicity
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 39m ago
Found something off?
comments(0)
5-min edit window · permanent after that